However, unlike EGFR mutations, pregnancy-associated lung cancers carrying ALK gene alterations did not show acute tumor progression after delivery; sustained disease remission was achieved through continued ALK-TKI therapy (24, 25). The gene discussed is ALK; the disease is lung cancer.